Increased serum concentration of immune cell derived microparticles in polymyositis/dermatomyositis

Immunology Letters

Volumn 128, Issue 2, 2010, Pages 124-130

  Baka, Zsuzsanna ^a   Senolt, Ladislav ^b   Vencovsky, Jiri ^b   Mann, Herman ^b   Simon, Piroska Sebestyén ^c   Kittel, Ágnes ^d   Buzás, Edit ^a   Nagy, György ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b CHARLES UNIVERSITY   (Czech Republic)

^c Javorszky Odon Hospital   (Hungary)

^d INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

Anti Jo 1 antibody; Dermatomyositis; Microparticles; Polymyositis

Indexed keywords

C REACTIVE PROTEIN; CD14 ANTIGEN; CD19 ANTIGEN; CD3 ANTIGEN; CREATINE KINASE; JO 1 ANTIBODY; MATRIX METALLOPROTEINASE; MONOCYTE CHEMOTACTIC PROTEIN;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; BLOOD LEVEL; CELL ULTRASTRUCTURE; CLINICAL ARTICLE; CONTROLLED STUDY; DERMATOMYOSITIS; ELECTRON MICROSCOPY; ENZYME ACTIVITY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; LUNG; MALE; MEMBRANE MICROPARTICLE; MONOCYTE; MUSCLE STRENGTH; MUSCLE WEAKNESS; NONHUMAN; PATHOGENESIS; POLYMYOSITIS; PRIORITY JOURNAL; RARE DISEASE; SKIN DEFECT; T LYMPHOCYTE; ULTRACENTRIFUGATION;

ANTIBODIES, ANTINUCLEAR; B-LYMPHOCYTES; CELL-DERIVED MICROPARTICLES; CREATINE KINASE; DERMATOMYOSITIS; FEMALE; FLOW CYTOMETRY; HUMANS; MALE; MICROSCOPY, ELECTRON; MIDDLE AGED; MONOCYTES; POLYMYOSITIS; T-LYMPHOCYTES;

EID: 77249125254     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2009.12.018     Document Type: Article

References (33)

1. Wolf P. The nature and significance of platelet products in human plasma. Br J Haematol 1967, 13:269-288.
2. Pap E., Pállinger E., Pásztói M., Falus A. Highlights of a new type of intercellular communication: microvesicle-based information transfer. Inflamm Res 2009, 58:1-8.
3. Distler J.H., Pisetsky D.S., Huber L.C., Kalden J.R., Gay S., Distler O. Microparticles as regulators of inflammation: novel players of cellular crosstalk in the rheumatic diseases. Arthritis Rheum 2005, 52:3337-3348.
4. Targoff I.N. Polymyositis and dermatomyositis in adults. Oxford Textbook of Rheumatology 2004, 895-913. Oxford University Press. D.A. Isenberg, P.J. Maddison, P. Woo, D. Glass, F.C. Breedveld (Eds.).
5. Grundtman C., Malmström V., Lundberg I.E. Immune mechanisms in the pathogenesis of idiopathic inflammatory myopathies. Arthritis Res Ther 2007, 9:208.
6. Bohan A., Peter J.B. Polymyositis and dermatomyositis. N Engl J Med 1975, 292:344-347.
7. Isenberg D.A., Allen E., Farewell V., Ehrenstein M.R., Hanna M.G., Lundberg I.E., et al. International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease. Rheumatology (Oxford) 2004, 43:49-54.
8. Pap E., Pállinger E., Falus A., Kiss A.A., Kittel A., Kovács P., et al. T lymphocytes are targets for platelet- and trophoblast-derived microvesicles during pregnancy. Placenta 2008, 29:826-832.
9. Arahata K., Engel A.G. Monoclonal antibody analysis of mononuclear cells in myopathies. I. Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells. Ann Neurol 1984, 16:193-208.
10. Pedrol E., Grau J.M., Casademont J., Cid M.C., Masanes F., Fernandez-Sola J., et al. Idiopathic inflammatory myopathies. Immunohistochemical analysis of the major histocompatibility complex antigen expression, inflammatory infiltrate phenotype and activation cell markers. Clin Neuropathol 1995, 14:179-184.
11. Dalakas M.C., Hohlfeld R. Polymyositis and dermatomyositis. Lancet 2003, 362:971-982.
12. Benveniste O., Herson S., Salomon B., Dimitri D., Trebeden-Negre H., Jean L., et al. Long-term persistence of clonally expanded T cells in patients with polymyositis. Ann Neurol 2004, 56:867-872.
13. Bradshaw E.M., Orihuela A., McArdel S.L., Salajegheh M., Amato A.A., Hafler D.A., et al. A local antigen-driven humoral response is present in the inflammatory myopathies. J Immunol 2007, 178:547-556.
14. Brouwer R., Hengstman G.J., Vree Egberts W., Ehrfeld H., Bozic B., Ghirardello A., et al. Autoantibody profiles in the sera of European patients with myositis. Ann Rheum Dis 2001, 60:116-123.
15. Behrens L., Kerschensteiner M., Misgeld T., Goebels N., Wekerle H., Hohlfeld R. Human muscle cells express a functional costimulatory molecule distinct from B7.1 (CD80) and B7.2 (CD86) in vitro and in inflammatory lesions. J Immunol 1998, 161:5943-5951.
16. Sugiura T., Kawaguchi Y., Harigai M., Takagi K., Ohta S., Fukasawa C., et al. Increased CD40 expression on muscle cells of polymyositis and dermatomyositis: role of CD40-CD40 ligand interaction in IL-6, IL-8, IL-15, and monocyte chemoattractant protein-1 production. J Immunol 2000, 164:6593-6600.
17. MacKenzie A., Wilson H.L., Kiss-Toth E., Dower S.K., North R.A., Surprenant A. Rapid secretion of interleukin-1β by microvesicle shedding. Immunity 2001, 15:825-835.
18. Mesri M., Altieri D.C. Endothelial cell activation by leukocyte microparticles. J Immunol 1998, 161:4382-4387.
19. Nauta A.J., Trouw L.A., Daha M.R., Tijsma O., Nieuwland R., Schwaeble W.J., et al. Direct binding of C1q to apoptotic cells and cell blebs induces complement activation. Eur J Immunol 2002, 32:1726-1736.
20. Barry O.P., Kazanietz M.G., Pratico D., FitzGerald G.A. Arachidonic acid in platelet microparticles up-regulates cyclooxygenase-2-dependent prostaglandin formation via a protein kinase C/mitogen-activated protein kinase-dependent pathway. J Biol Chem 1999, 274:7545-7556.
21. Sprague D.L., Elzey B.D., Crist S.A., Waldschmidt T.J., Jensen R.J., Ratliff T.L. Platelet-mediated modulation of adaptive immunity: unique delivery of CD154 signal by platelet-derived membrane vesicles. Blood 2008, 111:5028-5036.
22. Gasser O., Schifferli J.A. Activated polymorphonuclear neutrophils disseminate anti-inflammatory microparticles by ectocytosis. Blood 2004, 104:2543-2548.
23. Jodo S., Xiao S., Hohlbaum A., Strehlow D., Marshak-Rothstein A., Ju S.T. Apoptosis-inducing membrane vesicles: a novel agent with unique properties. J Biol Chem 2001, 276:39938-39944.
24. Knijff-Dutmer E.A., Koerts J., Nieuwland R., Kalsbeek-Batenburg E.M., van de Laar M.A. Elevated levels of platelet microparticles are associated with disease activity in rheumatoid arthritis. Arthritis Rheum 2002, 46:1498-1503.
25. Berckmans R.J., Nieuwland R., Tak P.P., Boing A.N., Romijn F.P., Kraan M.C., et al. Cell-derived microparticles in synovial fluid from inflamed arthritic joints support coagulation exclusively via a factor VII-dependent mechanism. Arthritis Rheum 2002, 46:2857-2866.
26. Skriner K., Adolph K., Jungblut P.R., Burmester G.R. Association of citrullinated proteins with synovial exosomes. Arthritis Rheum 2006, 54:3809-3814.
27. Brogan P.A., Shah V., Brachet C., Harnden A., Mant D., Klein N., et al. Endothelial and platelet microparticles in vasculitis of the young. Arthritis Rheum 2004, 50:927-936.
28. Guiducci S., Distler J.H., Jüngel A., Huscher D., Huber L.C., Michel B.A., et al. The relationship between plasma microparticles and disease manifestations in patients with systemic sclerosis. Arthritis Rheum 2008, 58:2845-2853.
29. Shirafuji T., Hamaguchi H., Higuchi M., Kanda F. Measurement of platelet-derived microparticle levels using an enzyme-linked immunosorbent assay in polymyositis and dermatomyositis patients. Muscle Nerve 2009, 39:586-590.
30. Distler J.H., Jungel A., Huber L.C., Seemayer C.A., Reich C.F., Gay R.E., et al. The induction of matrix metalloproteinase and cytokine expression in synovial fibroblasts stimulated with immune cell microparticles. Proc Natl Acad Sci USA 2005, 102:2892-2897.
31. Targoff I.N. Update on myositis-specific and myositis-associated autoantibodies. Curr Opin Rheumatol 2000, 12:475-481.
32. + T-cell expansions in inclusion body myositis. Brain 2006, 129:986-995.
33. Greenberg S.A., Pinkus G.S., Amato A.A., Pinkus J.L. Myeloid dendritic cells in inclusion-body myositis and polymyositis. Muscle Nerve 2007, 35:17-23.